Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase 3 1Phase 2 1

Status

Completed 4

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2Dermatologic 2

Conditions

Pain 2Lymphoma, Follicular 2Acute Pain 2Skin Neoplasms 1Keratosis, Actinic 1

Interventions

Cyclophosphamide 910Carboplatin 788pembrolizumab 747Paclitaxel 744Bevacizumab 716Cisplatin 709Gemcitabine 621Docetaxel 584Rituximab 558Radiotherapy 548Dexamethasone 511Nivolumab 491Doxorubicin 445Fluorouracil 392Capecitabine 382Etoposide 358Pemetrexed 339Cytarabine 335Oxaliplatin 335Lenalidomide 328Prednisone 327Erlotinib Hydrochloride 323fludarabine phosphate 316Trastuzumab 305Leucovorin 299fludarabine 296Vincristine 288Bortezomib 284Filgrastim 284Cetuximab 277

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Has results × Diclofenac × Clear all
NCT01962987 2020-07-20

A Study Comparing Diclofenac Sodium Gel 3% to SolarazeĀ® (Diclofenac Sodium) Gel 3% in the Treatment of Actinic Keratosis

Actavis Inc.

Phase 3 Completed
476 enrolled 10 charts
Dermatologic

Keratosis, Actinic

NCT01982539 2020-05-07

Safety and Tolerability of ZipsorĀ® in Pediatric Subjects (Ages 12-17 Years) With Mild to Moderate Acute

Depomed

Phase 4 Completed
25 enrolled 8 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

NCT02287350 2017-07-11

Pharmacokinetics & Safety of Diclofenac Potassium Oral Solution in Ped. Subjects (2-12 Yrs) With Mild-Mod. Acute Pain

Depomed

Phase 4 Completed
51 enrolled 45 charts
Lymphoid

Lymphoma, Follicular, Pain, Acute Pain

NCT00601640 2017-03-23

Eflornithine and/or Diclofenac in Treating Patients With Sun-Damaged Skin

University of Arizona

Phase 2 Completed
184 enrolled 9 charts
Dermatologic

Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚔